The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Osteoarthritis Treatment-Global Market Insights and Sales Trends 2025
Synopsis
Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swelling, decreased range of motion, and, when the back is affected, weakness or numbness of the arms and legs. The most commonly involved joints are those near the ends of the fingers, at the base of the thumb, neck, lower back, knee, and hips. Joints on one side of the body are often more affected than those on the other. Usually the symptoms come on over years. It can affect work and normal daily activities. Unlike other types of arthritis, only the joints are typically affected.
The global Osteoarthritis Treatment market size is expected to reach US$ 6872.1 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Osteoarthritis Treatment in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Osteoarthritis Treatment market. Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Assistive Devices segment is estimated at % CAGR for the next seven-year period.
Owing to the growing lifestyle changes, increasing number of obesity cases, and an extensive rise in the geriatric population, cases of osteoarthritis are increasing in North America. As a result, the adoption of treatment and drugs is also increasing in the region. The availability of better treatment options, high awareness among the people, government reimbursement policies, and the willingness to take up treatment is expected to add up to the growth of the osteoarthritis treatment market in the region. In terms of the business opportunities, the U.S., Europe, and Asia Pacific are lucrative markets for osteoarthritis treatment and drugs due to high prevalence of the disease. Alternative and complementary medicines are of great interest to the patient population affected by osteoarthritis. In the U.S., alternative medicine segments are growing at a higher pace and have high potential for substantial research. Due to advancements in technology, osteoarthritis management becomes more focused towards effective treatment and this is expected to fuel the growth of the global osteoarthritis treatment market in the long run.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Osteoarthritis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Osteoarthritis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Osteoarthritis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Osteoarthritis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Osteoarthritis Treatment covered in this report include Pfizer, Johnson & Johnson, Novartis, GlaxoSmithKline, Zimmer Biomet, Stryker and Abbott, etc.
The global Osteoarthritis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Johnson & Johnson
Novartis
GlaxoSmithKline
Zimmer Biomet
Stryker
Abbott
Global Osteoarthritis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Osteoarthritis Treatment market, Segment by Type:
Drugs
Assistive Devices
Global Osteoarthritis Treatment market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Osteoarthritis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Osteoarthritis (OA) is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The most common symptoms are joint pain and stiffness. Initially, symptoms may occur only following exercise, but over time may become constant. Other symptoms may include joint swelling, decreased range of motion, and, when the back is affected, weakness or numbness of the arms and legs. The most commonly involved joints are those near the ends of the fingers, at the base of the thumb, neck, lower back, knee, and hips. Joints on one side of the body are often more affected than those on the other. Usually the symptoms come on over years. It can affect work and normal daily activities. Unlike other types of arthritis, only the joints are typically affected.
The global Osteoarthritis Treatment market size is expected to reach US$ 6872.1 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Osteoarthritis Treatment in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Osteoarthritis Treatment market. Drugs, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Assistive Devices segment is estimated at % CAGR for the next seven-year period.
Owing to the growing lifestyle changes, increasing number of obesity cases, and an extensive rise in the geriatric population, cases of osteoarthritis are increasing in North America. As a result, the adoption of treatment and drugs is also increasing in the region. The availability of better treatment options, high awareness among the people, government reimbursement policies, and the willingness to take up treatment is expected to add up to the growth of the osteoarthritis treatment market in the region. In terms of the business opportunities, the U.S., Europe, and Asia Pacific are lucrative markets for osteoarthritis treatment and drugs due to high prevalence of the disease. Alternative and complementary medicines are of great interest to the patient population affected by osteoarthritis. In the U.S., alternative medicine segments are growing at a higher pace and have high potential for substantial research. Due to advancements in technology, osteoarthritis management becomes more focused towards effective treatment and this is expected to fuel the growth of the global osteoarthritis treatment market in the long run.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Osteoarthritis Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Osteoarthritis Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Osteoarthritis Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Osteoarthritis Treatment sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Osteoarthritis Treatment covered in this report include Pfizer, Johnson & Johnson, Novartis, GlaxoSmithKline, Zimmer Biomet, Stryker and Abbott, etc.
The global Osteoarthritis Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Johnson & Johnson
Novartis
GlaxoSmithKline
Zimmer Biomet
Stryker
Abbott
Global Osteoarthritis Treatment market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Osteoarthritis Treatment market, Segment by Type:
Drugs
Assistive Devices
Global Osteoarthritis Treatment market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Osteoarthritis Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Osteoarthritis Treatment
1.1 Osteoarthritis Treatment Market Overview
1.1.1 Osteoarthritis Treatment Product Scope
1.1.2 Osteoarthritis Treatment Market Status and Outlook
1.2 Global Osteoarthritis Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Osteoarthritis Treatment Market Size by Region (2018-2029)
1.4 Global Osteoarthritis Treatment Historic Market Size by Region (2018-2023)
1.5 Global Osteoarthritis Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Osteoarthritis Treatment Market Size (2018-2029)
1.6.1 North America Osteoarthritis Treatment Market Size (2018-2029)
1.6.2 Europe Osteoarthritis Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Osteoarthritis Treatment Market Size (2018-2029)
1.6.4 Latin America Osteoarthritis Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Osteoarthritis Treatment Market Size (2018-2029)
2 Osteoarthritis Treatment Market by Type
2.1 Introduction
2.1.1 Drugs
2.1.2 Assistive Devices
2.2 Global Osteoarthritis Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Osteoarthritis Treatment Historic Market Size by Type (2018-2023)
2.2.2 Global Osteoarthritis Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Osteoarthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Osteoarthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Osteoarthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Osteoarthritis Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Osteoarthritis Treatment Revenue Breakdown by Type (2018-2029)
3 Osteoarthritis Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Osteoarthritis Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Osteoarthritis Treatment Historic Market Size by Application (2018-2023)
3.2.2 Global Osteoarthritis Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Osteoarthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Osteoarthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Osteoarthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Osteoarthritis Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Osteoarthritis Treatment Revenue Breakdown by Application (2018-2029)
4 Osteoarthritis Treatment Competition Analysis by Players
4.1 Global Osteoarthritis Treatment Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Osteoarthritis Treatment as of 2022)
4.3 Date of Key Players Enter into Osteoarthritis Treatment Market
4.4 Global Top Players Osteoarthritis Treatment Headquarters and Area Served
4.5 Key Players Osteoarthritis Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Osteoarthritis Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Osteoarthritis Treatment Products, Services and Solutions
5.1.4 Pfizer Osteoarthritis Treatment Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Johnson & Johnson
5.2.1 Johnson & Johnson Profile
5.2.2 Johnson & Johnson Main Business
5.2.3 Johnson & Johnson Osteoarthritis Treatment Products, Services and Solutions
5.2.4 Johnson & Johnson Osteoarthritis Treatment Revenue (US$ Million) & (2018-2023)
5.2.5 Johnson & Johnson Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Osteoarthritis Treatment Products, Services and Solutions
5.3.4 Novartis Osteoarthritis Treatment Revenue (US$ Million) & (2018-2023)
5.3.5 GlaxoSmithKline Recent Developments
5.4 GlaxoSmithKline
5.4.1 GlaxoSmithKline Profile
5.4.2 GlaxoSmithKline Main Business
5.4.3 GlaxoSmithKline Osteoarthritis Treatment Products, Services and Solutions
5.4.4 GlaxoSmithKline Osteoarthritis Treatment Revenue (US$ Million) & (2018-2023)
5.4.5 GlaxoSmithKline Recent Developments
5.5 Zimmer Biomet
5.5.1 Zimmer Biomet Profile
5.5.2 Zimmer Biomet Main Business
5.5.3 Zimmer Biomet Osteoarthritis Treatment Products, Services and Solutions
5.5.4 Zimmer Biomet Osteoarthritis Treatment Revenue (US$ Million) & (2018-2023)
5.5.5 Zimmer Biomet Recent Developments
5.6 Stryker
5.6.1 Stryker Profile
5.6.2 Stryker Main Business
5.6.3 Stryker Osteoarthritis Treatment Products, Services and Solutions
5.6.4 Stryker Osteoarthritis Treatment Revenue (US$ Million) & (2018-2023)
5.6.5 Stryker Recent Developments
5.7 Abbott
5.7.1 Abbott Profile
5.7.2 Abbott Main Business
5.7.3 Abbott Osteoarthritis Treatment Products, Services and Solutions
5.7.4 Abbott Osteoarthritis Treatment Revenue (US$ Million) & (2018-2023)
5.7.5 Abbott Recent Developments
6 North America
6.1 North America Osteoarthritis Treatment Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Osteoarthritis Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Osteoarthritis Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Osteoarthritis Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Osteoarthritis Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Osteoarthritis Treatment Market Dynamics
11.1 Osteoarthritis Treatment Industry Trends
11.2 Osteoarthritis Treatment Market Drivers
11.3 Osteoarthritis Treatment Market Challenges
11.4 Osteoarthritis Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
